Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial

(RTTNews) – Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from…

Globant: AI Demand Is Promising, But Growth Is Still Not There (NYSE:GLOB)

This article was written by Follow I am a dedicated financial risk manager and investor specializing…

Celebrating Five Years of Investing in Future Advisors: Schwab’s RIATA Scholarship Program Recognizes 15 Promising Students in 2025

WESTLAKE, Texas–(BUSINESS WIRE)– Today, Schwab Advisor Services, in partnership with Charles Schwab Foundation, announced the 15…

TUG: Promising Methodology, Weak Performance So Far (NASDAQ:TUG)

This article was written by Follow I am a stock analyst with over 20 years of…

SandRidge Energy Stock: Promising Early Results From Its Operated Cherokee (NYSE:SD)

This article was written by Follow Aaron Chow, aka Elephant Analytics has 15+ years of analytical…

Avalanche (AVAX) Faces Mixed Signals Amid Regulatory Delays and Promising Partnerships

Tony Kim Jul 12, 2025 03:16 Avalanche (AVAX) wavers as the SEC…

Bitcoin’s April Surge Sets Stage for a Promising Summer

Timothy Morano May 07, 2025 00:04 Bitcoin (BTC) experienced a remarkable 14.08%…

Revolut rejected secondaries sale promising $65bn valuation

Revolut recently turned down investors pushing for a secondary shares sale that would have seen the…

Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron’s Promising Phase 3 Results

This article was written by Follow With a background as an RN and an MBA, I…